Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 10, 2017
- Accepted for publication January 20, 2018
- Published online June 1, 2018.
Article Versions
- previous version (February 1, 2018 - 11:42).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Nusrat J. Begum*,1,
- Anne Thieme*,2,
- Nina Eberhardt2,
- Robert Tauber3,
- Calogero D’Alessandria2,
- Ambros J. Beer1,
- Gerhard Glatting1,
- Matthias Eiber†,2 and
- Peter Kletting†,1
- 1Department of Nuclear Medicine, Universität Ulm, Ulm, Germany
- 2Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; and
- 3Department of Urology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
- For correspondence or reprints contact: Peter Kletting, Klinik für Nuklearmedizin, Universität Ulm, D-89081 Ulm, Germany. E-mail: peter.kletting{at}uniklinik-ulm.de
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer
- Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic
- Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
- Kidney Doses in 177Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible?
- Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
- Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity
- Modeling and Predicting Tumor Response in Radioligand Therapy
- The Relevance of Dosimetry in Precision Medicine